CBD Rescheduling is a very big deal — it is historic
The very first time the federal government is admitting that a component of MJ has medical value
Epidiolex is 98% CBD, so I am giving the FDA/DEA a 98% of doing the right thing and rescheduling CBD
My final prediction is that CBD winds up on Schedule III
Which is the wrong place as it shouldn’t even be on the Schedule at all — there is simply no evidence that it has the same level of addictive potential as other meds on Schedule III
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.